Does Dr. OLUWASAYO ADEYEMO have financial conflicts of interest?

Dr. OLUWASAYO ADEYEMO (MD/MPH) has received a total of $2,060 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,060 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. OLUWASAYO ADEYEMO?

According to CMS Open Payments data, Dr. OLUWASAYO ADEYEMO received funding from ABBVIE ($534), TAKEDA PHARMACEUTICALS U.S.A ($384), and GILEAD SCIENCES ($240).

Does Dr. OLUWASAYO ADEYEMO receive research grants or speaking fees?

Dr. OLUWASAYO ADEYEMO has received $2,060 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. OLUWASAYO ADEYEMO

MD/MPHReal-Time Hydrated

Specialty: Internal Medicine, Gastroenterology

Practice Location: ABINGDON, MD 21009

NPI Number: 1205221777

LIFETIME INDUSTRY VALUE

$2,060

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ADEYEMO is a verified Internal Medicine, Gastroenterology practitioner based in ABINGDON, MD.

Between 2021 and 2024, Dr. ADEYEMO had an overall industry promotional and research financial footprint of $2,060 as recorded in the federal CMS Open Payments database.

$2,060 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADEYEMO's primary funding source is ABBVIE, which accounts for $534 (representing 25.9% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$534

25.9%

TAKEDA PHARMACEUTICALS U.S.A

Rank 2

$384

18.7%

GILEAD SCIENCES

Rank 3

$240

11.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.